ISSN: 1474-175X

Nature Reviews Cancer Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 462. It is an CC BY Journal with a Single blind Peer Review review system The scope of the journal is focused on Cancer, Tumor, Genome, Metastasis, Medicine. It has an SJR impact factor of 16.955 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 16.955.

Nature Reviews Cancer focuses its scope in these topics and keywords: cancer, death, stem, networks, mechanisms, emerging, drug, evidence, extraordinary, extremes, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

16.955

SJR Impact factor

462

H Index

105

Total Docs (Last Year)

337

Total Docs (3 years)

9854

Total Refs

9442

Total Cites (3 years)

186

Citable Docs (3 years)

27.46

Cites/Doc (2 years)

93.85

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer Cell Q1
Journal of Clinical Oncology Q1
Annals of Oncology Q1
JAMA oncology Q1
Molecular Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Overcoming inhibition

Long path to MYC inhibition approaches clinical trials

That time of the month

Herding vascular precursors

Going for the double

You're the one

Balancing act

Top scorer

Acting alone

Complex catastrophe

Recognizing differences

The complete guide to self sufficiency

SHOW MORE ARTICLES

Plant power

One size fits all

Know your enemy

Cylindromatosis: cause and treatment

Yeast as a model system for anticancer drug discovery

BRCA2: preventing a breakdown

Active state

The upper hand

All exits blocked

Flying beneath the radar

Extra boost

A perfect mismatch